SCHEMBL6955752

SCHEMBL6955752

O=C(O)C(Sc1c(Cl)cccc1Cl)C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.41
AKR1B1 P15121 1/20 0.41
ALDH1A1 P00352 2/20 0.40
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
HSD17B10 Q99714 1/20 0.38
KMT2A Q03164 2/20 0.37
FEN1 P39748 1/20 0.36
SLC1A3 P43003 2/20 0.36
SLC1A2 P43004 2/20 0.36
TERT O14746 1/20 0.36
MEN1 O00255 1/20 0.36
CXCL8 P10145 1/20 0.36
CES2 O00748 1/20 0.35
CES1 P23141 1/20 0.35
PDK1 Q15118 1/20 0.35
PDK2 Q15119 1/20 0.35
PDK3 Q15120 1/20 0.35
PDK4 Q16654 1/20 0.35
SLC1A1 P43005 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10829734 0.80 TYMP (0.43) TSHRAKR1B1ALDH1A1HSD17B10CXCL8
SCHEMBL6965317 0.78 ALDH1A1 (0.42) TSHRAKR1B1ALDH1A1CYP2C9CYP2C19
SCHEMBL6953122 0.75 ALDH1A1 (0.39) ALDH1A1CYP2C9HSD17B10KMT2ASLC1A3
SCHEMBL10829514 0.71 PPARG (0.51) ALDH1A1KMT2AMEN1
SCHEMBL9018802 0.70 CYP1A2 (0.39) TSHRAKR1B1ALDH1A1CYP2C9CYP2C19
SCHEMBL17751250 0.69 TERT (0.39) TSHRAKR1B1ALDH1A1KMT2AFEN1
SCHEMBL6965136 0.69 LMNA (0.46) ALDH1A1CYP2C9CYP2C19HSD17B10LMNA
SCHEMBL13816926 0.69 CYP1A2 (0.38) TSHRALDH1A1CYP2C9CYP2C19KMT2A
SCHEMBL3064663 0.68 FFAR1 (0.54) AKR1B1ALDH1A1KMT2AMEN1LMNA
SCHEMBL16973281 0.67 TSHR (0.41) TSHRAKR1B1ALDH1A1KMT2AFEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0729465-B1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2003-01-22 EP disclosed
US-6005103-A TREATMENT OF BACTERIAL AND VIRAL INFECTIONS AND DISEASES, INCLUDING AIDS WARNER-LAMBERT COMPANY (US) 1999-12-21 US disclosed
US-5808062-A AIDS THERAPY WARNER-LAMBERT COMPANY (US) 1998-09-15 US disclosed
EP-0729466-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
EP-0729465-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
WO-1995014013-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed
WO-1995014014-A2 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed